A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.